APA

Kooiman J., van Rein N., Spaans B., van Beers K. A. J., Bank J. R., van de Peppel W. R., del Sol A. I., Cannegieter S. C., Rabelink T. J., Lip G. Y. H., Klok F. A. & Huisman M. V. (20151019). Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease. : PloS one.

Chicago

Kooiman Judith, van Rein Nienke, Spaans Bas, van Beers Koen A J, Bank Jonna R, van de Peppel Wilke R, del Sol Antonio Iglesias, Cannegieter Suzanne C, Rabelink Ton J, Lip Gregory Y H, Klok Frederikus A and Huisman Menno V. 20151019. Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease. : PloS one.

Harvard

Kooiman J., van Rein N., Spaans B., van Beers K. A. J., Bank J. R., van de Peppel W. R., del Sol A. I., Cannegieter S. C., Rabelink T. J., Lip G. Y. H., Klok F. A. and Huisman M. V. (20151019). Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease. : PloS one.

MLA

Kooiman Judith, van Rein Nienke, Spaans Bas, van Beers Koen A J, Bank Jonna R, van de Peppel Wilke R, del Sol Antonio Iglesias, Cannegieter Suzanne C, Rabelink Ton J, Lip Gregory Y H, Klok Frederikus A and Huisman Menno V. Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease. : PloS one. 20151019.